Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Journal of Modern Laboratory Medicine ; (4): 145-146,150, 2017.
Article in Chinese | WPRIM | ID: wpr-663425

ABSTRACT

Objective To provide reference for cervical cancer control by compare the HPV infection rate and distribution Xianyang and Baoji area.Methods Analysed HPV subtypes results of 1 356 cases in Baoji area and 7 708 cases in Xianyang area,and compared the age distribution,subtypes and positive rate of HPV infection in the women of the two areas.Results The HPV positive rate was 35.91% in Baoji area,and 32.14% in Xianyang area respectively.The most popular single subtype was HPV16,58,52 in the two areas.The dual-infection was most popular was HPV multiple infection in the two ar-eas.The HPV81 and HPV73 were not detected out in Baoji area,and all 23 HPV subtypes were detected out in Xianyang ar-ea.Conclusion The HPV infection rate in Baoji was higher than Xianyang(P<0.01).The high-risk HPV subtypes were same in the two areas.The HPV positive rate was high in all age groups.

2.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 907-910, 2014.
Article in Chinese | WPRIM | ID: wpr-294374

ABSTRACT

Clinical trial protocol is the document that illustrates the background of a clinical trial, theoretic basis, objective, design, methods, and organization, as well as statistical calculating, implement, and conditions for completion. Clinical trial protocol is the basic measure for ensuring the validity of scientific results and reducing bias. In order to optimize the design of clinical trial protocol, we generalize main problems in Chinese medicine clinical trials, key points of clinical trial protocol, as well as report standards.


Subject(s)
Humans , Clinical Trials as Topic , Drugs, Chinese Herbal , Therapeutic Uses , Medicine, Chinese Traditional , Research Design , Reference Standards
3.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 872-874, 2012.
Article in Chinese | WPRIM | ID: wpr-288500

ABSTRACT

Currently, the number of systematic reviews on Chinese medicine (CM) increases gradually. However, the quality of the reviews varied, which resulted in great limitations in guiding clinical practice. This article refers to the Cochrane Handbook and PRISMA Statement to introduce the reporting specification of the systematic review, including asking a research question, review methods, presentation of the results, discussion and conclusion. We analyzed the methodology issues in the published systematic reviews on CM in order to improve the quality of future reviews.


Subject(s)
Medicine, Chinese Traditional , Research Design , Review Literature as Topic , Writing , Reference Standards
SELECTION OF CITATIONS
SEARCH DETAIL